SBRA · NASDAQ · REIT - Healthcare Facilities

Sabra Health Care REIT (SBRA)

Healthcare REIT earning rent and resident fees from nursing and senior-housing properties.

$19.79
vs last close−0.09 (−0.43%)
Loading prices…

Sabra Health Care REIT, Inc.SBRA
Real Estate

Owns and finances skilled-nursing, senior-housing, behavioral-health, and specialty-hospital real estate across the U.S. and Canada. Revenue comes from tenant rent, resident fees at managed senior housing, and credit investments, tying results to third-party operators, managers, healthcare reimbursement, and regulation.

Owns and finances healthcare real estate across the U.S. and Canada, centered on skilled-nursing and transitional-care facilities, leased and managed senior housing, behavioral-health sites, and specialty hospitals. Leased properties produce rent from third-party operators; managed communities generate resident fees while outside managers run day-to-day operations. Loans, preferred equity, and joint ventures add credit-investment income.

Uses a management team with healthcare operating experience and a network of local, regional, and national operators to source investments and transition properties between tenants or management structures. Recent investment activity remains focused on senior housing and skilled nursing.

Cash flow depends on tenant and borrower performance, managed-community occupancy and operating costs, and third-party managers' execution. Skilled-nursing operators also depend heavily on government reimbursement, while healthcare regulation and REIT distribution requirements shape the business.

Company facts

CEORichard K. Matros
ListedNov 16, 2010
ExchangeNASDAQ
HeadquartersTustin, CA
CountryUnited States
Employees58
CIK0001492298
ISINUS78573L1061

Market cap$5.01B
EPS (ttm)$0.2624
P/E (ttm)75.72
ROE2.3%
P/B1.82
P/S5.83
Dividend yieldDiv yield6.04%
Beta−0.18vs XLRE 0.80

Price target$22.00+10.7%Average of 29 analysts
ConsensusHold16 of 29 analysts
Ratings

Target rangeAs of Sep 21, 2026

Latest analyst notes

DateFirmActionPriorCurrent
Aug 31, 2026Mizuho SecuritiesTarget
Target:
Target: $21
Aug 31, 2026BarclaysReiterate
Rating: Target: $21
Rating: MixedTarget: $23
Aug 6, 2026Raymond JamesUpgrade
Rating: Underperform
Rating: Market Perform
Jul 22, 2026UBSTarget
Target: $19
Target: $25
Jul 22, 2026Robert W. BairdTarget
Target: $16
Target: $23

Next report
Nov 4, 26
in 43 days
EPS estimate
$0.17
Revenue estimate
$234.0M
Fiscal quarter
Q3 FY26

EPSReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26Apr '26Aug '26Nov '26
Reported$0.20$0.17$0.28$0.09$0.11$0.16−$0.10Pending
Estimate$0.16$0.17$0.18$0.18$0.17$0.17$0.17$0.17
Surprise+25.0%−2.0%+55.6%−48.7%−35.3%−4.0%−158.4%

RevenueReportedEstimate

Feb '25May '25Aug '25Nov '25Feb '26Apr '26Aug '26Nov '26
Reported$182.3M$183.5M$189.2M$190.0M$211.9M$221.8M$235.9MPending
Estimate$178.4M$179.0M$180.9M$186.8M$198.0M$209.2M$219.4M$234.0M
Surprise+2.2%+2.5%+4.6%+1.7%+7.0%+6.0%+7.5%
Estimate$0.17
ReportedDue Nov 4, 2026
Estimate$234.0M
ReportedDue Nov 4, 2026
View details

Debt to equity96.20%
Current ratio4,367.60%

ProfitabilityRevenueNet incomeNet margin

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Revenue$178.0M$182.3M$183.5M$189.2M$190.0M$211.9M$221.8M$235.9M
Net income$29.8M$46.7M$40.3M$65.5M$22.5M$27.2M$40.9M−$25.2M
Net margin16.7%25.6%22.0%34.7%11.9%12.8%18.4%0.0%

GrowthOperating income

Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
Operating income$64.4M$67.3M$67.4M$71.9M$59.6M$64.6M$39.5M−$61.8M
YoY growth−36.3%+23.9%+16.3%+7.4%−7.5%−4.0%−41.4%Turned loss

Balance sheet, Jun 30, 2026Cash & short-term investments $231.6M · Total debt $2.65B · Total assets $5.51B · Shareholders' equity $2.75B

Revenue
$235.9M
Operating income
−$61.8M
Net income
−$25.2M
View details

Dividend yield
6.04%
Next ex-date
Nov 14, 26
estimated · in 53 days
Annual dividend
$1.20
per share
Schedule
Quarterly
4 payments a year

HistoryDividendAnnual yield

Nov '24Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26
Dividend$0.30$0.30$0.30$0.30$0.30$0.30$0.30$0.30
Annual yield6.60%7.26%6.72%6.50%6.46%5.95%5.81%5.91%
Ex-dateNov 15Feb 14May 16Aug 15Nov 17Feb 13May 15Aug 14
Payment dateNov 29Feb 28May 30Aug 29Nov 28Feb 27May 29Aug 31
View details

Institutions≈ 102.78%262.56M shares
473 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail
Insiders0.98%2.50M shares
12 holders · as of Sep 9, 2026
Strategic holders13.00%33.20M shares
1 holder · as of Jan 27, 2022
Adds to116.76%

255.46M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing

This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.

These groups come from separate filings that can overlap, so they add to 116.76%; nothing is left for Other.

Top shareholders13F · 13D/G · Form 4

HolderStakeSharesDate
BlackRock, Inc.Institution
16.29%41.61Mas of Jun 30, 2026
BlackRock, Inc.Strategic
13.00%33.20Mfiled Jan 27, 2022
Principal Financial Group IncInstitution
9.67%24.71Mas of Jun 30, 2026
Vanguard Portfolio Management LLCInstitution
9.14%23.35Mas of Jun 30, 2026
Principal Real Estate Investors LLCInstitution
8.35%21.33Mfiled Feb 6, 2026

Insider tradesForm 4

DateInsiderRoleSharesAvg price
Sep 8, 2026Richard K. Matrosdirector, officer: Chair, CEO and President−200,000$20.83
Mar 25, 2026Jessica Floresofficer: Executive VP & CAO−15,231$19.86
View details

Compare

CompanyPriceChange
Sabra Health Care REIT$19.79−0.43%$5.01B75.727.35.8+24.7%
Omega Healthcare Investors$46.28−1.17%$14.01B16.723.810.8+11.5%
CareTrust REIT$37.32−0.96%$8.90B23.423.016.4+37.4%
LTC Properties$42.25−1.47%$2.19B15.421.56.3−46.2%
National Health Investors$67.27−0.88%$3.29B19.619.87.6+1.6%
Welltower$230.77−0.85%$167.72B123.283.313.3+39.1%
American Healthcare REIT$51.91−0.75%$10.81B76.974.64.3+23.7%
Ventas$86.98−0.06%$42.31B161.2120.46.6+21.7%
Medical Properties Trust$3.58−2.05%$2.18B154.32.1+7.9%
Median23.449.27.1+16.6%